Priority Date: 20.07.12 (EP 20120177351)

OSTEOPONTIN PEPTIDE FRAGMENTS FOR USE IN SUPPRESSION OR PREVENTION OF TUMOR GROWTH

  • Application ID: EP13739429
  • Status: APPLICATION DEEMED TO BE WITHDRAWN

Applicants

Technology company logo small
Technology Company

Attorney

Employment test 11 - 50 employees
Company dna guardian ip consulting i slash s
operating since 2009
Headquarter in Lyngby and 1 office
active in Legal Services, IP Consulting, and IP Portfolio Processing

Specialization

This EP application has the IPC class A61, C07, and C12. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 127 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 20.07.2012 - Priority Date (EP 20120177351)
  • 23.01.2014 - Publication A1 (WO2014013060)
  • 27.05.2015 - Publication A1 (EP2875134)